首页 › 基金 › Versor Investments LP › APGE

Versor Investments LP 对 APGE 的持仓历史

APOGEE THERAPEUTICS INC

Versor Investments LP 在 Q2 2026 的 13F 申报中披露持有 APGE(APOGEE THERAPEUTICS INC)18,222 股,市值约 US$2.4M,约占其申报组合的 5.09%,在其申报持仓中市值排名第 7 位。 Versor Investments LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)18.22K 股
申报持仓市值$2.42M
组合权重5.09%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Versor Investments LP 对 APGE 的持仓演变

Versor Investments LP 于 Q2 2026 首次披露 APGE 持仓:18,222 股(约 US$2.4M)。

逐季持仓明细

季度股数金额变化
Q2 2026 18.22K $2.42M 新进

关于 APGE 与 13F 数据

APGE(APOGEE THERAPEUTICS INC)的行业分类暂缺。我们追踪的基金中还有 60 只申报持有 APGE,申报仓位最大的包括:Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 APGE 的基金

查看 APGE 的全部基金持有人 →

常见问题

How long has Versor Investments LP held APGE?

Versor Investments LP has disclosed APGE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Versor Investments LP's current position in APGE?

As of Q2 2026, Versor Investments LP holds 18.22K shares of APGE (APOGEE THERAPEUTICS INC), valued at $2.42M, representing 5.09% of its reported portfolio and ranking #7.

Has Versor Investments LP been buying or selling APGE?

In the latest 13F filing (Q2 2026), Versor Investments LP newly opened its position in APGE.

Which other funds hold APGE?

Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.